Klaria Pharma Holding AB (publ) issues notice to attend the annual general meeting
The shareholders in Klaria Pharma Holding AB (publ), reg. no. 556959-2917, are hereby given notice to attend the annual general meeting on 24 March 2022.Special arrangements due to the risk for spread of the virus COVID-19 (coronavirus) The board of directors has, in light of continued spread of the coronavirus and in accordance with the Swedish Act on temporary exceptions to facilitate the execution of general meetings in companies and other associations which is expected to enter into force on 1 March 2022, decided that the annual general meeting shall be held without physical presence